Renal cell carcinoma: A clinicopathological follow-up study after radical nephrectomy

Scandinavian Journal of Urology and Nephrology

Volumn 41, Issue 3, 2007, Pages 191-197

  Zubac, Dragomir P ^a   Bostad, Leif ^b   Gestblom, Charlotta ^c   Kihl, Björn ^c   Seidal, Tomas ^c   Wentzel Larsen, Tore ^a   Bakke, August M ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c CENTRAL HOSPITAL   (Sweden)

Author keywords

Grading; Necrosis; Renal cell carcinoma; Staging; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OVERALL SURVIVAL; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; TUMOR NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NECROSIS; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SWEDEN;

EID: 34247645026     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590601016552     Document Type: Article

References (31)

1. Atlas of cancer incidence in Sweden. Linköping: Swedish Oncological Centres; 1995.
2. Ficarra V, Martignoni G, Maffei N, Brunelli M, Novara M, Zanolla L, et al. Original and reviewed nuclear grading according to the Fuhrman system. A multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 2005;103:68-75.
3. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002;168:2395-400.
4. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma. A Swiss experience with 588 tumours. Cancer 2000;89:604-14.
5. Wunderlich H, Dreihaupt M, Schlichter A, Kosmehl H, Reichelt O, Schubert J. New cut-off point between T1 and T2 renal cell carcinoma - necessary for a better discriminatory power of TNM classification. Urol Int 2004;72:123-8.
6. Zisman A, Pantuck AJ, Chao D, Dorey F, Said JW, Gitlitz BJ, et al. Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome. J Urol 2001;166:54-8.
7. Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, Venturiana MDP, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002;26:281-91.
8. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005;23:2763-71.
9. Al-Aynati M, Chen V, Salama S, Shuhaibar H, Treleaven D, Vincic L. Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch Pathol Lab Med 2003;127:593-6.
10. Lanigan D, Conroy R, Barry-Walsh C, Loftus B, Royston D, Leader M. A comparative analysis of grading systems in renal adenocarcinoma. Histopathology 1994;24:473-6.
11. Lang H, Lindner V, de Fromont M, Molinie V, Letourneux H, Meyer N, et al. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma. Assessment of 241 patients with >15 year follow-up. Cancer 2005;103:625-9.
12. Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 2005;104:511-20.
13. Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005;173:48-51.
14. Oken NM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
15. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag; 2002. p. 323-8.
16. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, et al. The Heidelberg classification of renal cell tumours. J Pathol 1997;183:131-3.
17. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63.
18. Zisman A, Pantuck AJ, Wieder J, Chao DH, Dorey F, Said JW, et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002;20:4559-66.
19. Therneau TM, Grambsch PM. Modelling survival data: extending the Cox model. New York: Springer-Verlag; 2000.
20. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.
21. Giuliani L, Giberti C, Martorana G, Rovida S. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 1990;143:468-74.
22. Bretheau D, Lechevallier E, de Fromont M, Sault MC, Rampal M, Coulange C. Prognostic value of nuclear grade of renal cell carcinoma. Cancer 1995;76:2543-9.
23. Minervini R, Minervini A, Fontana C, Traversi C, Cristofani R. Evaluation of the 1997 tumour, nodes and metastases classification of renal cell carcinoma: experience in 172 patients. BJU Int 2000;86:199-202.
24. Delahunt B, Kittelson JM, McCredie MRE, Reeve AE, Stewart JH, Bilous AM. Prognostic importance of tumour size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumour categories and comparison with other prognostic parameters. Cancer 2002;94:658-64.
25. Ficarra V, Guille F, Schips L, de la Taile A, Galetti TP, Tostain J, et al. Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer 2005;104:2116-23.
26. Steiner T, Knels R, Schubert J. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma. Eur Urol 2004;46:327-30.
27. Hafez KS, Fergany AF, Novic AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumour size on patient survival, tumor recurrence and TNM staging. J Urol 1999;162:1930-3.
28. Frank I, Blute ML, Leibovich BC, Bradley C, Cheville JC, Lohse CM, et al. pT2 classification for renal cell carcinoma. Can its accuracy be improved? J Urol 2005;173:380-4.
29. Cindolo L, de la Taille A, Messina G, Romis L, Abbou CC, Altieri A, et al. A preoperative clinical prognostic model for non-metastatic renal cell carcinoma. BJU Int 2003;92:901-5.
30. Zisman A, Pantuck AJ, Dorey F, Said JW, Shvarts O, Quintana D, et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 2001;19:1649-57.
31. Minervini A, Lilas L, Minervini R, Selli C. Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal cell carcinoma: long-term analysis in 213 patients. Cancer 2002;94:2590-5.